Thorne HealthTech Dividends and Buybacks
Dividend criteria checks 0/6
Thorne HealthTech does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 12
Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar
Jun 07Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist
Dec 17Thorne HealthTech Grows But Faces Macro Headwinds
Sep 09Thorne HealthTech's blood collection device OneDraw gets clearance in Japan
Aug 23Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised
Aug 09Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies
Jun 05Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality
Mar 23Thorne HealthTech: Good Potential At A Low Price
Jan 11Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if THRN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if THRN's dividend payments have been increasing.
Dividend Yield vs Market
| Thorne HealthTech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (THRN) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.5% |
| Industry Average (Personal Products) | 3.0% |
| Analyst forecast (THRN) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate THRN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate THRN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate THRN's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as THRN has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/18 03:10 |
| End of Day Share Price | 2023/10/13 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Thorne HealthTech, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Bryan Spillane | BofA Global Research |
| Susan Anderson | Canaccord Genuity |